January 26, 2025
Press Release
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Recent News &
Trending Topics
Check out what's new with Eisai. Explore content that highlights our commitment to pursuing breakthrough solutions and medicines to enrich people's lives.
Tackling the toughest disease areas to bring patients closer to hope
Neurology
Our goal is to revolutionize drug discovery and develop targeted medicines for some of the most challenging neurological conditions, primarily Alzheimer’s disease.
Learn more about Neurology
Learn More 
Oncology
We won’t stop pursuing breakthroughs until the world is cancer-free. That’s why we let the science drive us to new approaches that accelerate progress.
Learn more about Oncology
Learn More
Exploring the depths of human biology
Our innovation begins in our R&D organization. We call this group and the approach it employs Deep Human Biology Learning (DHBL). This approach to science leverages our unique strengths with scientific advances.
Our Patient Focus
The inspiration for our innovations comes from the people we serve. We spend time with them to understand their needs and provide support throughout their healthcare journey.
-
Community Involvement
-
Corporate Responsibility
-
Patient Programs
Community Involvement
We spend time in our communities to learn about the people we serve. Find out about Eisai sponsorships, volunteering and other ways we live our human health care mission.
Corporate Responsibility
Discover how we make real contributions to patients and their families while observing the highest level of integrity.
Patient Programs
Diseases aren't the only adversities people face. Learn about the ways we help patients and their families throughout their health journey.
One Team
Looking for a team environment where you’ll be challenged to break through? Join our human health care mission to make a difference in the lives of patients.